Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 10, 2004

View Archived Issues

Traditional Chinese medicine shows neuroprotective effects in vivo

Chinese herb derivative attenuates neuronal damage in diabetic mice

Ista submits sNDA for Vitrase as spreading agent

New formulation of Solon launched in Japan

Lonza to manufacture Dynepo

Mycobacterial cell wall-DNA complex may present vaccine potential against bladder carcinoma

Subgroup analysis of FOCUS study in ADHD

Topline results from Opterone study

Inactine phase III study progresses

FDA clearance for Captia HSV IgG Specific ELISAs

Canadian NDS filing for Histrelin Hydrogel Implant

Hybridon licenses VEGF rights to Alnylam for ocular indications

Preclinical animal safety studies completed for CytoGenix' antiherpes compound

Cubicin phase III study cleared to continue after third safety review

First chemotherapy combination study for KRX-0401

Progression of ASCENT trial of DN-101 plus Taxotere for AIPC

Bioxalis expands pipeline

Chemotherapeutic agents target microtubules synergistically

Two series of vanilloid VR1 antagonists prepared and tested at Neurogen

New 5-HT receptor antagonists with potential as antidepressants claimed by Abbott

Novel thrombopoietin mimetics under development at GSK

Two series of NPY Y5 antagonists presented by Pfizer scientists

BMS scientists design new HER inhibitors for cancer therapy

New cathepsin inhibitors covered by AstraZeneca patent

Pfizer researchers identify novel chemokine CCR1 antagonists

EP-2104R MRI contrast agent enters clinical testing

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...